Hydroxyzine Eg

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzine Eg, is a first-generation antihistamine presented as an oral dosage form for oral use. It is used to manage allergic skin reactions, pruritus, anxiety, sedation and nausea in appropriate patients.

GNH USA supplies Hydroxyzine Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Hydrochloride is a first‑generation antihistamine that blocks peripheral H1 receptors to relieve allergic and related conditions.

Allergic skin reactions: reduces itching and inflammation associated with hives or dermatitis. Pruritus: alleviates intense itching caused by dermatologic disorders. Anxiety: provides short‑term relief of anxiety symptoms. Sedation: induces calming effects useful before procedures. Nausea: helps control nausea related to allergic responses.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivary flow causing thirst. - Dizziness: light‑headed sensation, especially when standing quickly. - Blurred vision: temporary focus changes. - Constipation: slowed intestinal motility. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heartbeat, potentially life‑threatening. - Severe allergic reaction (anaphylaxis): rapid onset of swelling, difficulty breathing, or rash.

Hydroxyzine Eg should be used with caution in certain populations and conditions. - Assess hepatic function: adjust use if severe liver impairment is present. - Monitor CNS depression: elderly patients may be more susceptible to sedation. - Avoid alcohol: may intensify drowsiness and impair coordination. - Use cautiously in glaucoma: anticholinergic effects can increase intra‑ocular pressure. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Hydroxyzine Eg may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - CNS depressants (e.g., opioids, benzodiazepines): increased sedation and respiratory depression. - QT‑prolonging agents (e.g., macrolide antibiotics, fluoroquinolones): heightened risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., diphenhydramine): additive anticholinergic side effects. - Alcohol: may enhance drowsiness and impair alertness. - MAO inhibitors: potential for exaggerated hypotensive response.